Pleuro-pulmonary solitary fibrous tumors: A clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (α/β), c-met, and EGFR

American Journal of Surgical Pathology

Volumn 32, Issue 11, 2008, Pages 1627-1642

  Schirosi, Laura ^a   Lantuejoul, Sylvie ^e   Cavazza, Alberto ^c   Murer, Bruno ^b   Brichon, Pierre Yves ^f   Migaldi, Mario ^a   Sartori, Giuliana ^a   Sgambato, Alessandro ^d   Rossi, Giulio ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Hospital Umberto i   (Italy)

^c Mestre and Azienda St Maria Nuova   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e INSERM   (France)

^f HÔPITAL MICHALLON   (France)

Author keywords

C met; P53; PDGFR; Solitary fibrous tumor; Stage; Tyrosine kinases

Indexed keywords

B RAF KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN P53; SCATTER FACTOR RECEPTOR; STEM CELL FACTOR; BRAF PROTEIN, HUMAN; PLATELET DERIVED GROWTH FACTOR RECEPTOR; STEM CELL FACTOR RECEPTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; EXON; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SOLITARY FIBROUS TUMOR; TUMOR CLASSIFICATION; TUMOR NECROSIS; BIOSYNTHESIS; DISEASE FREE SURVIVAL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENETICS; KAPLAN MEIER METHOD; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; DISEASE-FREE SURVIVAL; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-KIT; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SOLITARY FIBROUS TUMOR, PLEURAL; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 56149084392     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31817a8a89     Document Type: Article

References (113)

1. Ali SZ, Hoon V, Hoda S, et al. Solitary fibrous tumor. A cytologichistologic study with clinical, radiologic, and immunohistochemical correlations. Cancer. 1997;81:116-121.
2. Allen TC, Cagle PT, Churg AM, et al. Localized malignant mesothelioma. Am J Surg Pathol. 2005;29:866-873.
3. Allt G, Lawrenson JG. Pericytes: cell biology and pathology. Cells Tissues Organs. 2001;169:1-11.
4. Amary MF, Berisha F, Bernardi FC, et al. Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma. Mod Pathol. 2007;20: 482-496.
5. Amo-Takyi BK, Günther K, Peters I, et al. Benign solitary fibrous pleural tumour. Evidence of primitive features and complex genomic imbalances, including loss of 20q. APMIS. 2001;109: 601-606.
6. Argani P, Zakowski MF, Klimstra DS, et al. Detection of the SYTSSX chimeric RNA of synovial sarcoma in paraffin-embedded tissue and its application in problematic cases. Mod Pathol. 1998; 11:65-71.
7. Aubry MC, Bridge JA, Wickert R, et al. Primary monophasic synovial sarcoma of the pleura: five cases confirmed by the presence of SYT-SSX fusion transcript. Am J Surg Pathol. 2001;25:776-781.
8. Bennasroune A, Gardin A, Aunis D, et al. Tyrosine kinase receptors as attractive targets of cancer therapy. Crit Rev Oncol Hematol. 2004;50:23-38.
9. Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature. 2001; 411:355-365.
10. Bongiovanni M, Viberti L, Pecchioni C, et al. Steroid hormone receptor in pleural solitary fibrous tumours and CD34+ progenitor stromal cells. J Pathol. 2002;198:252-257.
11. Bourdon JC. p53 and its isoforms in cancer. Br J Cancer. 2007; 97:277-282.
12. Briselli M, Mark EJ, Dickersin GR. Solitary fibrous tumors of the pleura: eight new cases and review of 360 cases in the literature. Cancer. 1981;47:2678-2689.
13. Brozzetti S, D'Andrea N, Limiti MR, et al. Clinical behavior of solitary fibrous tumors of the pleura: an immunohistochemical study. Anticancer Res. 2000;20:4701-4706.
14. Brunnemann RB, Ro JY, Ordonez NG, et al. Extrapleural solitary fibrous tumor: a clinicopathologic study of 24 cases. Mod Pathol. 1999;12:1034-1042.
15. Burger H, den Bakker MA, Kros JM, et al. Activating mutations in c-kit and PDGFRalpha are exclusively found in gastrointestinal stromal tumors and not in other tumors overexpressing these imatinib mesylate target genes. Cancer Biol Ther. 2005;4: 1270-1274.
16. Butnor KJ, Burchette JL, Sporn TA, et al. The spectrum of kit (CD117) immunoreactivity in lung and pleural tumors. A study of 96 cases using a single-source antibody with a review of literature. Arch Pathol Lab Med. 2004;128:538-543.
17. Caravajal Galbis JM, Sales Badia JGS, Navarro HM, et al. Localized fibrous tumors of the pleura: clinical and surgical evaluation. Arch Bronconeumol. 2004;40:419-421.
18. Cardillo G, Facciolo F, Cavazzana AO, et al. Localized (solitary) fibrous tumors of the pleura: an analysis of 55 patients. Ann Thorac Surg. 2000;70:1808-1812.
19. Carretta A, Bandiera A, Melloni G, et al. Solitary fibrous tumors of the pleura: immunohistochemical analysis and evaluation of prognostic factors after surgical treatment. J Surg Oncol. 2006;94:40-44.
20. Cavazza A, Rossi G, Agostani L, et al. Cytokeratin positive malignant solitary fibrous tumor of the pleura: an unusual pitfall in the diagnosis of pleural spindle cell neoplasms. Histopathology. 2003;43:606-608.
21. Chan JKC. Solitary fibrous tumour-everywhere, and a diagnosis in vogue. Histopathology. 1997;31:568-576.
22. Chang ED, Lee EH, Won YS, et al. Malignant solitary fibrous tumor of the pleura causing recurrent hypoglycemia: immunohistochemical stain of insulin-like growth factor I receptor in three cases. J Korean Med Sci. 2001;16:220-224.
23. Chang YL, Lee YC, Wu CT. Thoracic solitary fibrous tumor: clinical and pathological diversity. Lung Cancer. 1999;23:53-60.
24. Chaugle H, Parchment C, Grotte GJ, et al. Hypoglycemia associated with solitary fibrous tumour of the pleura. Eur J Cardiothorac Surg. 1999;15:84-86.
25. Chiara F, Goumans MJ, Forsberg H, et al. A gain of function mutation in the activation loop of platelet-derived growth factor β-receptor deregulates its kinase activity. J Biol Chem. 2004;41: 42516-42527.
26. Claesson-Welsh L. Platelet-derived growth factor receptor signals. J Biol Chem. 1994;269:32023-32026.
27. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949-954.
28. de Leval L, Defraigne JO, Hermans G, et al. Malignant solitary fibrous tumor of the pleura: report of a case with cytogenetic analysis. Virchows Arch. 2003;442:388-392.
29. de Perrot M, Kurt AM, Robert JH, et al. Clinical behaviour of solitary fibrous tumors of the pleura. Ann Thorac Surg. 1999; 67:1456-1459.
30. de Perrot M, Fischer S, Brundler MA, et al. Solitary fibrous tumors of the pleura. Ann Thorac Surg. 2002;74:285-293.
31. de Saint Aubain Somerhausen N, Rubin BP, Fletcher CDM. Myxoid solitary fibrous tumor: a study of seven cases with emphasis on differential diagnosis. Mod Pathol. 1999;12:463-471.
32. Debiec-Rychter M, de Wever I, Hagemeijer A, et al. Is 4q13 a recurring breakpoint in solitary fibrous tumors? Cancer Genet Cytogenet. 2001;131:69-73.
33. Debiec-Rychter M, Dumez H, Judson I, et al. Use of c-KIT/ PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC soft tissue and bone sarcoma group. Eur J Cancer. 2004;40:689-695.
34. Di Renzo MF, Narsimhan RP, Olivero M, et al. Expression of Met/HGF receptor in normal and neoplastic human tissues. Oncogene. 1991;6:1997-2003.
35. Dibb NJ, Dilworth SM, Mol CD, et al. Switching on kinases: oncogenic activation of BRAF and the PDGFR family. Nat Rev. 2004;4:718-727.
36. England DM, Hochholzer L, McCarthy MJ. Localized benign and malignant fibrous tumors of the pleura: a clinicopathologic review of 223 cases. Am J Surg Pathol. 1989;13:640-658.
37. English JC, Leslie KO. Pathology of the pleura. Clin Chest Med. 2006;27:157-180.
38. Essary LR, Vargas SO, Fletcher CD. Primary pleuropulmonary synovial sarcoma: reappraisal of a recently described anatomic subset. Cancer. 2002;94:459-469.
39. Fletcher CDM, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33:459-465.
40. Flint A, Weiss SW. CD34 and keratin expression distinguishes solitary fibrous tumor (fibrous mesothelioma) of pleura from desmoplastic mesothelioma. Hum Pathol. 1995;26:428-431.
41. Fukasawa Y, Takada A, Tateno M, et al. Solitary fibrous tumor of the pleura causing recurrent hypoglycemia by secretion of insulinlike growth factor II. Pathol Int. 1998;48:47-52.
42. Gengler C, Guillou L. Solitary fibrous tumour and haemangiopericytoma: evolution of a concept. Histopathology. 2006;48:63-74.
43. Gerhardt H, Betsholtz C. Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res. 2003;314:15-23.
44. Gold JS, Antonescu CR, Hajdu C, et al. Clinicopathologic correlates of solitary fibrous tumors. Cancer. 2002;94:1057-1068.
45. Graadt van Roggen JF, Hogendoorn PCW. Solitary fibrous tumour: the emerging clinicopathologic spectrum of an entity and its differential diagnosis. Curr Diagn Pathol. 2004;10:229-235.
46. Hanau CA, Miettinen M. Solitary fibrous tumor: histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites. Hum Pathol. 1995;26:440-449.
47. Heinrich MC, Corless CL, Duesing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003;299: 708-710.
48. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev. 1999;79:1283-1316.
49. Hellstrom M, Kalen M, Lindhal P, et al. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryogenic blood vessel formation in the mouse. Development. 1999;126:3047-3055.
50. Hernandez FJ, Fernandez BB. Localized fibrous tumors of pleura: a light and electron microscopic study. Cancer. 1947;34:1667-1674.
51. Hiraoka K, Morikawa T, Ohbuchi T, et al. Solitary fibrous tumors of the pleura: clinicopathological and immunohistochemical examination. Int Cardiovasc Thorac Surg. 2003;2:61-64.
52. Hirota S, Ohashi A, Nishida T, et al. Gain of function mutations of platelet derived growth factor receptor a gene in gastrointestinal stromal tumors. Gastroenterology. 2003;125:660-667.
53. Hubbard SR, Till JH. Protein tyrosine kinase structure and function. Annu Rev Biochem. 2000;69:373-398.
54. Hunter T. Signaling-2000 and beyond. Cell. 2000;100:113-127.
55. Ide F, Obara K, Mishima K, et al. Ultrastructural spectrum of solitary fibrous tumor: a unique perivascular tumor with alternative lines of differentiation. Virchows Arch. 2005;446:646-652.
56. Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al. Effect of the tyrosine kinase inhibition STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med. 2001;344: 1052-1056.
57. Jones AV, Cross NCP. Oncogenic derivatives of platelet-derived growth factor receptors. Cell Mol Life Sci. 2004;61:2912-2923.
58. Kaplan MA, Goodman MD, Satish J, et al. Primary pulmonary sarcoma with morphologic features of monophasic synovial sarcoma and chromosome translocation t(X;18). Am J Clin Pathol. 1996;105:195-199.
59. Kindblom LG, Remotti HE, Aldenberg F, et al. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol. 1998;152:1259-1269.
60. Kitamura Y, Hirota S. Kit as a human oncogenic tyrosine kinase. Cell Mol Life Sci. 2004;61:2924-2931.
61. Klemperer P, Rabin CB. Primary neoplasms of the pleura: a report of five cases. Arch Pathol. 1931;11:385-412.
62. Krismann M, Adams H, Jaworska M, et al. Patterns of chromosomal imbalances in benign solitary fibrous tumours of the pleura. Virchows Arch. 2000;437:248-255.
63. Lee SC, Tzao C, Ou SM, et al. Solitary fibrous tumors of the pleura: clinical, radiological, surgical and pathological evaluation. EJSO. 2005;31:84-87.
64. Lindhal P, Johansson BR, Leveen P, et al. Pericyte loss and microaneurysm formation in PDGF-B deficient mice. Science. 1997;277:242-245.
65. Liu Y, Wilkinson FL, Kirton JP, et al. Hepatocyte growth factor and c-met expression in pericytes: implications for atherosclerotic plaque development. J Pathol. 2007;212:12-19.
66. Longati P, Comoglio PM, Bardelli A. Receptor tyrosine kinases as therapeutic targets: the model of the MET oncogene. Curr Drug Targets. 2001;2:41-55.
67. Ma PC, Maulik G, Christensen J, et al. c-Met: structure, functions and potential for therapeutic inhibition. Cancer Metastasis Rev. 2003;22:309-325.
68. Madhusudan S, Ganesan TS. Tyrosine kinase inhibitors in cancer therapy. Clin Biochem. 2004;37:618-635.
69. Miettinen M, Lasota J. KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol. 2005;13:205-220.
70. Miettinen M, Sarlomo-Rikala M, Kovatich AJ. Cell-type-and tumor-type-related patterns of bcl-2 reactivity in mesenchymal cells and soft tissue tumours. Virchows Arch. 1998;433:255-260.
71. Mitsudomi T, Kosaka T, Yatabe Y. Biological and clinical implications of EGFR mutations in lung cancer. Int J Clin Oncol. 2006;11:190-198.
72. Moran CA, Suster S, Koss MN. The spectrum of histologic growth patterns in benign and malignant fibrous tumours of the pleura. Semin Diagn Pathol. 1992;9:169-180.
73. Morimitsu Y, Nakajima M, Hisaoka M, et al. Extrapleural solitary fibrous tumor: clinicopathologic study of 17 cases and molecular analysis of p53 pathway. APMIS. 2000;108:617-625.
74. Naito Y, Ishii G, Kawai O, et al. D2-40-positive solitary fibrous tumors of the pleura: diagnostic pitfall of biopsy specimen. Pathol Int. 2007;57:618-621.
75. Nicholson AG, Goldstraw P, Fisher C. Synovial sarcoma of the pleura and its differentiation from other primary pleural tumors: a clinicopathologic and immunohistochemical review of three cases. Histopathology. 1998;33:508-513.
76. Noble ME, Endicott JA, Johnson LN. Protein kinase inhibitors: insights into drug design from structure. Science. 2004;303: 1800-1805.
77. Normanno N, De Luca A, Bianco C. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene. 2006;366:2-16.
78. Okike N, Bernatz PE, Woolner LB. Localized mesothelioma of the pleura. Benign and malignant variants. J Thorac Cardiovasc Surg. 1978;75:363-370.
79. Ordonez NG. Localized (solitary) fibrous tumor of the pleura. Adv Anat Pathol. 2000;7:327-340.
80. Rena O, Filosso PL, Papalia E, et al. Solitary fibrous tumour of the pleura: surgical treatment. Eur J Cardiothorac Surg. 2001;19:185-189.
81. Renshaw AA. O13 (CD99) in spindle cell tumors: reactivity with hemangiopericytoma, solitary fibrous tumor, synovial sarcoma, and meningioma but rarely with sarcomatoid mesothelioma. Appl Immunohistochem. 1995;3:250-256.
82. Renshaw AA, Pinkus GS, Corson JM. CD34 and AE1/AE3, diagnostic discriminants in the distinction of solitary fibrous tumour of the pleura from sarcomatoid mesothelioma. Appl Immunohistochem. 1994;2:94-102.
83. Robinson LA. Solitary fibrous tumor of the pleura. Cancer Control. 2006;13:264-269.
84. Robinson LA, Reilly RB. Localized pleural mesothelioma. The clinical spectrum. Chest. 1994;106:1611-1615.
85. Rossi G, Schirosi L, Giovanardi F, et al. Pleural malignant solitary fibrous tumor with sarcomatous overgrowth showing PDGFRβ mutation. Chest. 2006;130:581-583.
86. Saifuddin A, De Costa P, Chalmers AG, et al. Primary malignant localized fibrous tumours of the pleura: clinical, radiological, and pathological features. Clin Radiol. 1992;45:13-17.
87. Sanchez-Mora N, Cebollero-Presmanes M, Monroy V, et al. Clinicopathological features of solitary fibrous tumors of the pleura: a case series and literature review. Arch Bronconeumol. 2006;42:96-99.
88. Sawada N, Ishiwata T, Naito Z, et al. Immunohistochemical localization of endothelial cell markers in solitary fibrous tumor. Pathol Int. 2002;52:769-776.
89. Sawyers CL. Rational therapeutic intervention in cancer: kinases as drug targets. Curr Opin Genet Dev. 2002;12:111-115.
90. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2000;103:211-225.
91. Schmidt L, Duh FM, Chen F, et al. Germline and somatic mutations in the tyrosine kinase domain of the MET protooncogene in papillary renal carcinomas. Nat Genet. 1997;16:68-73.
92. Shidham VB, Chivukula M, Gupta D, et al. Immunohistochemical comparison of gastrointestinal stromal tumor and solitary fibrous tumor. Arch Pathol Lab Med. 2002;126:1189-1192.
93. Sihto H, Sarlomo-Rikala M, Tynninen O, et al. KIT and plateletderived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors. J Clin Oncol. 2005;23:1-9.
94. Song S, Ewald AJ, Stallcup W, et al. PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat Cell Biol. 2005;7:870-879.
95. Stout AP, Murray MR. Localized pleural mesothelioma: investigation of its characteristics and histogenesis by the method of tissue culture. Arch Pathol. 1942;34:951-964.
96. Sun Y, Naito Z, Ishiwata T, et al. Basic FGF and Ki-67 proteins useful for immunohistological diagnostic evaluations in malignant solitary fibrous tumor. Pathol Int. 2003;53:284-290.
97. Sung SH, Chang JW, Kim J, et al. Solitary fibrous tumors of the pleura: surgical outcome and clinical course. Ann Thorac Surg. 2005; 79:303-307.
98. Suster S, Fisher C, Moran CA. Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract. Am J Surg Pathol. 1998;22:863-872.
99. Travis WD, Brambilla E, Muller-Hermelink HK, et al, eds. Tumours of the lung, pleura, thymus and heart. Pathology & genetics. World Health Organization Classification of Tumours. Lyon: IARC Press; 2004.
100. Utley JR, Parker JC, Hahn RS, et al. Recurrent benign fibrous mesothelioma of the pleura. J Thorac Cardiovasc Surg. 1973; 65:830-834.
101. Vallat-Decouvelaere AV, Dry SM, Fletcher CDM. Atypical and malignant solitary fibrous tumors in extrathoracic locations. Evidence of their comparability to intra-thoracic tumors. Am J Surg Pathol. 1998;22:1501-1511.
102. van de Rijn M, Rouse RV. CD34, a review. Appl Immunohistochem. 1994;2:71-80.
103. van de Rijn M, Lombard CM, Rouse RV. Expression of CD34 by solitary fibrous tumors of the pleura, mediastinum, and lung. Am J Surg Pathol. 1994;18:814-820.
104. Vousden KH, Lane DP. P53 in health and disease. Nat Rev Mol Cell Biol. 2007;8:275-283.
105. Wagner E. Das tuberkelahnliche lymphadenom (Der cytogene oder reticulirte Tuberkel). Arch Heilk (Leipzig). 1870;11:497.
106. Wan PT, Garnett MJ, Roe SM, et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell. 2004;116:855-867.
107. Webb CP, Hose CD, Koochekpour S, et al. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-Met-urokinase plasminogen activator plasmin proteolytic network. Cancer Res. 2000;60:342-349.
108. Wellbrock C, Karasarides M, Marais F. The RAF proteins take centre stage. Nat Rev Mol Cell Biol. 2004;5:875-885.
109. Went P, Dirnhofer S, Bundi M, et al. Prevalence of KIT expression in human tumors. J Clin Oncol. 2004;22:4514-4522.
110. Witkin GB, Rosai J. Solitary fibrous tumor of the mediastinum. A report of 14 cases. Am J Surg Pathol. 1989;13:547-557.
111. Yan B, Raju GC, Salto-Tellez M. Epithelioid, cytokeratin expressing malignant solitary fibrous tumour of the pleura. Pathology. 2008;40:98-99.
112. Yokoi T, Tsuzuki T, Yatabe Y, et al. Solitary fibrous tumour: significance of p53 and CD34 immunoreactivity in its malignant transformation. Histopathology. 1998;32:423-432.
113. Yousem SA, Flynn SD. Intrapulmonary localized fibrous tumor. Intraparenchymal so-called localized fibrous mesothelioma. Am J Clin Pathol. 1988;89:365-369.